Janssen submits Marketing Authorisation Application for daratumumab

Daratumumab is for European patients with heavily pre-treated multiple myeloma
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Practical therapeutics mAbs Haematology Oncology Research anti-CD38 monoclonal antibody daratumumab GEN501 immunomodulatory agents Latest News MMY2002 multiple myeloma Source Type: news